TRAZODONE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for trazodone hydrochloride and what is the scope of freedom to operate?
Trazodone hydrochloride
is the generic ingredient in four branded drugs marketed by Angelini Pharma, Pragma, Accord Hlthcare, Aiping Pharm Inc, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Crossmedika Sa, Granules, Graviti Pharms, Natco, Norvium Bioscience, Oxford Pharms, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms, and is included in thirty-five NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Trazodone hydrochloride has seventy-eight patent family members in thirty countries.
There are thirteen drug master file entries for trazodone hydrochloride. Thirty-nine suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for TRAZODONE HYDROCHLORIDE
International Patents: | 78 |
US Patents: | 2 |
Tradenames: | 4 |
Applicants: | 25 |
NDAs: | 35 |
Drug Master File Entries: | 13 |
Finished Product Suppliers / Packagers: | 39 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 65 |
Patent Applications: | 2,402 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRAZODONE HYDROCHLORIDE |
What excipients (inactive ingredients) are in TRAZODONE HYDROCHLORIDE? | TRAZODONE HYDROCHLORIDE excipients list |
DailyMed Link: | TRAZODONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alzheimer's Drug Discovery Foundation | Phase 3 |
Simon Ducharme, MD | Phase 3 |
University of New Mexico | Phase 4 |
Generic filers with tentative approvals for TRAZODONE HYDROCHLORIDE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 300MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 150MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 100MG | TABLET;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for TRAZODONE HYDROCHLORIDE
Drug Class | Serotonin Reuptake Inhibitor |
Medical Subject Heading (MeSH) Categories for TRAZODONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TRAZODONE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OLEPTRO | Extended-release Tablets | trazodone hydrochloride | 150 mg and 300 mg | 022411 | 1 | 2010-10-18 |
US Patents and Regulatory Information for TRAZODONE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accord Hlthcare | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 206923-002 | Sep 8, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Norvium Bioscience | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 090514-004 | Jun 2, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Norvium Bioscience | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 090514-003 | Jun 2, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRAZODONE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | DESYREL | trazodone hydrochloride | TABLET;ORAL | 018207-003 | Mar 25, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | DESYREL | trazodone hydrochloride | TABLET;ORAL | 018207-003 | Mar 25, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRAZODONE HYDROCHLORIDE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | PI0615860 | composição farmacêutica de liberação prolongada, forma de dosagem sólida de liberação prolongada, e, método | ⤷ Sign Up |
Georgia, Republic of | P20135915 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | ⤷ Sign Up |
Norway | 20081593 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.